Veriti Management LLC Moderna, Inc. Transaction History

Veriti Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $204,545 - $336,718	2,021 Added 41.04%	6,945 $824,000
Q1 2024 Apr 19, 2024	BUY	$85.37 - $115.44 $101,419 - $137,142	1,188 Added 31.8%	4,924 $524,000
Q4 2023 Feb 05, 2024	BUY	$69.51 - $104.43 $259,689 - $390,150	3,736 New	3,736 $371,000
Q2 2023 Jul 13, 2023	BUY	$118.5 - $160.53 $18,130 - $24,561	153 Added 6.44%	2,527 $307,000
Q1 2023 Apr 26, 2023	SELL	$135.66 - $197.02 $55,213 - $80,187	-407 Reduced 14.64%	2,374 $364,000
Q4 2022 Jan 20, 2023	BUY	$118.38 - $210.04 $89,140 - $158,160	753 Added 37.13%	2,781 $0
Q3 2022 Oct 26, 2022	SELL	$118.07 - $194.18 $31,642 - $52,040	-268 Reduced 11.67%	2,028 $240,000
Q2 2022 Jul 18, 2022	BUY	$117.13 - $176.59 $31,976 - $48,209	273 Added 13.49%	2,296 $328,000
Q1 2022 Apr 11, 2022	BUY	$126.46 - $235.05 $69,805 - $129,747	552 Added 37.53%	2,023 $348,000
Q4 2021 Jan 19, 2022	SELL	$225.82 - $368.51 $14,452 - $23,584	-64 Reduced 4.17%	1,471 $374,000
Q3 2021 Oct 08, 2021	BUY	$221.9 - $484.47 $340,616 - $743,661	1,535 New	1,535 $591,000

940

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.